Page last updated: 2024-08-22

platinum and Abdominal Neoplasms

platinum has been researched along with Abdominal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, DT; Dieterich, S; Hofmann, LV; Kothary, N; Louie, JD; Sze, DY1
Hoskins, WJ; Jones, WB; Lewis, JL; Rubin, SC; Vaccarello, L; Vlamis, V; Wong, G1
Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K1

Other Studies

3 other study(ies) available for platinum and Abdominal Neoplasms

ArticleYear
Percutaneous implantation of fiducial markers for imaging-guided radiation therapy.
    AJR. American journal of roentgenology, 2009, Volume: 192, Issue:4

    Topics: Abdominal Neoplasms; Adult; Aged; Contrast Media; Equipment Design; Female; Gold; Humans; Male; Middle Aged; Platinum; Prostheses and Implants; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Thoracic Neoplasms; Tomography, X-Ray Computed

2009
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Gynecologic oncology, 1995, Volume: 57, Issue:1

    Topics: Abdominal Neoplasms; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Platinum; Reoperation; Retrospective Studies; Survival Analysis

1995
[CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
    Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:10

    Topics: Abdominal Neoplasms; Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Platinum; Recurrence; Remission Induction; Thrombocytopenia

1989